IN2014DN10669A - - Google Patents

Info

Publication number
IN2014DN10669A
IN2014DN10669A IN10669DEN2014A IN2014DN10669A IN 2014DN10669 A IN2014DN10669 A IN 2014DN10669A IN 10669DEN2014 A IN10669DEN2014 A IN 10669DEN2014A IN 2014DN10669 A IN2014DN10669 A IN 2014DN10669A
Authority
IN
India
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
salt
Prior art date
Application number
Other languages
English (en)
Inventor
Edward Savory
Martyn Pritchard
Mike Ashwood
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1211788.3A external-priority patent/GB201211788D0/en
Priority claimed from GBGB1304812.9A external-priority patent/GB201304812D0/en
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Publication of IN2014DN10669A publication Critical patent/IN2014DN10669A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN10669DEN2014 2012-07-03 2013-07-03 IN2014DN10669A (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1211788.3A GB201211788D0 (en) 2012-07-03 2012-07-03 Pro-drug compounds
GBGB1304812.9A GB201304812D0 (en) 2013-03-15 2013-03-15 Pro-drug compounds
PCT/GB2013/051767 WO2014006407A1 (en) 2012-07-03 2013-07-03 Pro-drug compounds

Publications (1)

Publication Number Publication Date
IN2014DN10669A true IN2014DN10669A (it) 2015-08-28

Family

ID=48782540

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10669DEN2014 IN2014DN10669A (it) 2012-07-03 2013-07-03

Country Status (7)

Country Link
US (2) US20140011773A1 (it)
EP (1) EP2870148A1 (it)
AU (1) AU2013285164A1 (it)
CA (1) CA2877578A1 (it)
IN (1) IN2014DN10669A (it)
WO (1) WO2014006407A1 (it)
ZA (1) ZA201409213B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140011773A1 (en) 2012-07-03 2014-01-09 Proximagen Limited Pro-drug Compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds
CN114010788A (zh) 2014-08-22 2022-02-08 奥克兰联合服务有限公司 通道调节剂
US11717506B2 (en) * 2019-05-07 2023-08-08 The Johns Hopkins University Neuroprotective compounds for amyotrophic lateral sclerosis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126311B1 (en) 1983-05-18 1989-09-13 Beecham Group Plc Benzopyran derivatives.
EP0139992B1 (en) 1983-09-01 1988-12-28 Beecham Group Plc Chromanol derivatives
EP0301713A3 (en) 1987-07-07 1990-05-02 Beecham Group Plc Chroman derivatives for treatment of pulmonary hypertension
NZ258611A (en) 1992-12-11 1997-07-27 Smithkline Beecham Plc 4-benzoyl(or heteroarylcarbonyl)amino-3,4-dihydro- 3-hydroxy-2h-benzo[b]pyran derivatives;benzopyrano[4,3-d]oxazole intermediates
NZ258610A (en) 1992-12-11 1997-05-26 Smithkline Beecham Plc Various 4-acylamino-2h-benzo[b]pyran-3-ol derivatives;use in preparation of medicaments
ATE263770T1 (de) 1994-02-04 2004-04-15 Smithkline Beecham Plc Verfahren zum epoxidieren prochiral olefine
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
DE69524871T2 (de) 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel
GB9813949D0 (en) 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
CA2586410A1 (en) 2004-12-23 2006-07-06 Xenoport, Inc. Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
WO2009147442A1 (en) 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
US20110319482A1 (en) 2008-06-05 2011-12-29 Peter Blower Novel treatments
AU2010325755A1 (en) 2009-12-03 2012-06-21 Proximagen Ltd Treatment of infectious diseases
RU2012124837A (ru) 2009-12-03 2014-01-10 Проксимэджен ЛТД Лечение аллодинии и гипералгезии
US20140011773A1 (en) 2012-07-03 2014-01-09 Proximagen Limited Pro-drug Compounds
GB201304814D0 (en) 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds

Also Published As

Publication number Publication date
US20140011773A1 (en) 2014-01-09
US9499510B2 (en) 2016-11-22
CA2877578A1 (en) 2014-01-09
EP2870148A1 (en) 2015-05-13
AU2013285164A1 (en) 2015-01-22
US20150322034A1 (en) 2015-11-12
ZA201409213B (en) 2016-07-27
WO2014006407A1 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
MX2015002040A (es) Baricitinib deuterado.
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
MX2015001246A (es) Ibrutinib deuterado.
PH12014502169A1 (en) N-cyclylamides as nematicides
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
IN2015DN01035A (it)
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
TW201231056A (en) Metal salt compositions
UA118666C2 (uk) Похідні піразолу
MY191628A (en) Novel triazolo[4,5-d]pyrimidine derivatives
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX359825B (es) Compuesto pirazol y su uso farmaceutico.
MX2014014832A (es) Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.
JOP20130342B1 (ar) تكوين ثابت من بيميتركس
MY182328A (en) Pyridine-2-amides useful as cb2 agonists
PH12015501088A1 (en) Dimeric compounds
MX346248B (es) Derivados de [1,2,3]triazol[4,5-d]pirimidina como agonistas de los agonistas del receptor canabinoide 2.
PH12015502178A1 (en) Pyridinylpyrazoloquinoline compound
MX349373B (es) Nuevos derivados de pirazina.
IN2014DN10669A (it)
IN2014DN07996A (it)
MX2015008829A (es) Momelotinib deuterado.
PH12015501146A1 (en) Hydantoin derivative
PH12015500399A1 (en) Azaindolines
GB201020397D0 (en) Compounds